Oversight Committee

The Oversight Committee is a critical part of program operations. They are opinion leaders in their areas and provide high-level guidance for they program based on their backgrounds in venture capital, regulatory affairs, academia, technology transfer, and medicine.

Alan Wright

Alan T. Wright, M.D., MPH

Chief Medical Officer, Roche Diagnostics Corporation

Bryce Pilz

Bryce Pilz

Director of Licensing, University of Michigan Office of Technology Transfer

(734) 615-0358

Daniel Avram Orringe

Daniel Orringer, MD

Assistant Professor of Neurosurgery, Medical School

(734) 936-7010

Danny Sachs

Danny Sachs, MD

Associate Director of Entrepreneurship & medicine, University of Minnesota Medical Devices Center Innovation Fellows Program

hugo braun

Hugo Braun

Co-Founder, North Coast Technology Investors, LP

Jack Ball

Jack Ball

CEO and Board Member, Solulink

James Ashton-Miller, Ph.D.

James Ashton-Miller, Ph.D.

Associate Chair for Translational Research, U-M Department of Biomedical Engineering

(734) 763-2320

Jim Adox

Jim Adox

Managing Director, Venture Investors

John Janik

John Janik

PhD, Director of Strategic Development, Stryker

Lonnie Shea, Ph.D.

Lonnie Shea, Ph.D.

William and Valerie Hall Chair, Biomedical Engineering Professor, Biomedical Engineering

Louis Cannon

Louis Cannon, M.D., FACC, FCCP, FACP, FACA, FSCAI

Founder, Senior Managing Director, BioStar Ventures

Mark Cohen, MD

Mark Cohen, MD

Associate Professor of Surgery and Pharmacology, Director of Endocrine Surgery Research, U-M Medical School

Peter Galen

Peter Galen

President & CEO, Brien Holden Vision Diagnostic, Inc.

Renard Charity

Renard Charity

Director, Fletcher Spaght Ventures

Russ King

Russ King

President & Managing Partner, MethodSense

Sean Chambers

Sean Chambers, Ph.D.

Engineering Manager – Research, Cook Medical

 

Licensing Representative(s) from U-M Office of Technology Transfer (OTT has one vote)